Low-dose methotrexate as a potential treatment for schizophrenia via astrocytic and neuroimmune modulation. Lima TSA, Corsi-Zuelli F, Souza AJ, Colodete DAE, et al. Schizophr Res 2025;284:67-76.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lima TSA, Corsi-Zuelli F, Souza AJ, Colodete DAE, et al. Low-dose methotrexate as a potential treatment for schizophrenia via astrocytic and neuroimmune modulation. Schizophr Res 2025;284:67-76.
PMID: 40749304